Skip to main content

Table 3 Univariate and multivariate analysis for factors associated with myocardial injury

From: Myocardial injury in hospitalized COVID-19 patients: a retrospective study, systematic review, and meta-analysis

Clinical factors

Univariate analysis

Multivariate analysis

Odds ratio

95% confidence interval

P value

Odds ratio

95% confidence interval

P value

Age (years)

1.06

1.04–1.08

< 0.001

1.05

1.02–1.1

0.00

Sex

1.01

0.56–1.80

0.981

Hypertension

3.06

1.37–6.81

0.006

1.37

0.56–3.36

0.48

Diabetes mellitus

1.33

0.73–2.40

0.354

Cardiovascular disease

4.12

2.24–7.56

< 0.001

2.0

1.1–4.0

0.04

 Ischemic heart disease

2.82

1.46–5.44

0.002

 HFrEF

4.67

1.50–14.49

0.008

 HFpEF

3.04

1.31–7.05

0.009

 Atrial fibrillation

3.39

1.49–7.73

0.004

ESRD on HD

7.07

1.99–25.07

0.002

6.62

1.7–25

0.06

Hospital course and clinical outcome

EKG findings

      

 Arrhythmia

5.46

2.47–12.07

< 0.001

3.04

1.1–9.3

0.04

 Atrial fibrillation

3.53

1.49–8.37

0.004

 1st degree heart block

1.84

0.33–10.30

0.488

 New BBB

0.75

0.24–2.28

0.606

 ST depression or T wave inversion

2.34

1.09–4.97

0.027

 QT prolongation

2.08

1.11–3.90

0.022

 Abnormal EKG

3.47

1.90–6.34

< 0.001

Abnormal BNP

4.95

2.27–10.82

< 0.001

3.03

1.3–7.2

0.01

High d-dimer

2.40

1.11–5.20

0.026

1.2

0.4–3.5

0.73

Acute kidney injury

6.54

3.39–12.62

< 0.001

4.5

1.8–11

0.001

Invasive ventilation

1.35

0.66–2.75

0.408

Shock of any type

3.70

1.85–7.39

< 0.001

ARDS

1.44

0.67–3.08

0.354

Ischemic stroke

3.73

0.23–60.61

0.354

Length of stay

0.99

0.96–1.03

0.865

Do not resuscitate and Comfort care

4.66

2.49–8.71

< 0.001

Discharge to skilled Nursing facility

2.94

1.41–6.10

0.004

Death

4.25

2.09–8.61

< 0.001

In hospital medications

 Hydroxychloroquine

0.73

0.39–1.36

0.316

 Anticoagulation

1.76

1.01–3.06

0.046

 ACEi/ARNi

0.47

0.18–1.27

0.14

 Steroids

3.73

1.84–7.57

< 0.001

  1. HFpEF congestive heart failure with preserved ejection fraction, HFrEF congestive heart failure with reduced ejection, ARNI angiotensin receptor-neprilysin inhibitor, ESRD on HD End stage renal disease on hemodialysis, BBB bundle branch block (complete left or right). OR for continuous variables is calculated for 1-unit increments